Avastin for breast cancer will not be removed from the compendia listings used to determine off-label reimbursement, according to DNA’s webcast in progress.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.